Matrix-dependent gene expression of Egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells

Hypertension

Volumn 34, Issue 5, 1999, Pages 1141-1146

  Ling, Shanhong ^b   Dai, Aozhi ^b   Ma, Yunn Hwa ^a   Wilson, Emily ^a   Chatterjee, Kanu ^c   Ives, Harlan E ^a   Sudhir, Krishnankutty ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALFRED HOSPITAL   (Australia)

^c NONE

Author keywords

Angiotensin II; Early growth response 1 gene; Matrix; Platelet derived growth factor

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; COLLAGEN; FIBRONECTIN; LAMININ; LOSARTAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA SYNTHESIS; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEWBORN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR SMOOTH MUSCLE;

EID: 0032704854     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1141     Document Type: Article

References (30)

1. Folkow B. "Structural factor" in primary and secondary hypertension. Hypertension. 1990;16:89-101.
2. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation: contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61: 181-186.
3. Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat: role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res. 1982;51:280-289.
4. Mulvany MJ, Baandrup U, Gundersen HJ. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertension rats using a three-dimensional dissector. Circ Res. 1985;57:794-800.
5. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 1988;62:30G-35G.
6. Weber H, Taylor DS, Molloy CJ. Angiotensin II induced delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest. 1994;93:788-798.
7. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
8. Mangiarua EI, Palmer VL, Lloyd LL, McCumbee WD. Platelet-derived growth factor mediates angiotensin II-induced DNA synthesis in vascular smooth muscle cells. Arch Physiol Biochem. 1997;105:151-157.
9. Berk BC, Rao GN. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol. 1993;154:368-380.
10. Wang DH, Prewitt RL, Beebe SJ. Regulation of PDGF-A: a possible mechanism for angiotensin II-induced vascular growth. Am J Physiol. 1995;269(pt 2):H356-H364.
11. Parrott DP, Lockey PM, Bright CP. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells. Atherosclerosis. 1991;88:213-218.
12. Millar JA, Harris EL, Cassie NJ. Mitogenesis in cultured vascular smooth muscle cells from two rat models of hypertension in response to fetal calf serum and angiotensin II. J Cardiovasc Pharmacol. 1990;16(suppl 7):S14-S16.
13. Araki S, Kawahara Y, Karija K, Sunako M, Tsuda T, Fukuzaki H, Yashimi T. Stimulation of platelet-derived growth factor-induced DNA synthesis by angiotensin II in rabbit vascular smooth muscle cells. Biochem Biophys Res Commun. 1990;168:350-357.
14. Bunkenburg B, Van Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1992;20: 746-754.
15. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res. 1992;70:820-828.
16. Sudhir K, Wilson E, Chatterjee K, Ives HE. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest. 1993;92:3003-3007.
17. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/imegrin interactions. J Clin Invest. 1995;96:2364-2372.
18. Patel MK, Betteridge LJ, Hughes AD, Clunn GF, Schachter M, Shaw RJ, Sever PS. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens. 1996;14:341-347.
19. Campbell-Boswell M, Roberson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol. 1981;35:265-276.
20. Assender JW, Irenius E, Fredholm BB. 5-Hydroxytryptamine, angiotensin and bradykinin transiently increase intracellular calcium concentrations and PKC-alpha activity, but do not induce mitogenesis in human vascular smooth muscle cells. Acta Physiol Scand. 1997;160:207-217.
21. Conroy SC, Hart CE, Perez-Reyes N, Giachelli CM, Schwartz SM, McDougall JK. Characterization of human aortic smooth muscle cells expressing HPV16E6 and E7 open reading frames. Am J Pathol. 1995; 147:753-762.
22. Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998;101: 527-535.
23. Field SL, Khachigian LM, Sleigh MJ, Yang G, Vandermark SE, Hogg PJ, Chesterman CN. Extracellular matrix is a source of mitogenically active platelet-derived growth factor. J Cell Physiol. 1996;168:322-332.
24. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest. 1992;90:456-461.
25. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol. 1995;50:191-224.
26. Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes: a paradigm of transcriptional activation in vascular endothelium. Circ Res. 1997;81:457-461.
27. Khachigian LM, Anderson KR, Halnon HJ, Gimbrone MA Jr, Resnick N, Collins T. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arterioscler Thromb Vasc Biol. 1997;17: 2280-2286.
28. Wilson E, Vives F, Collins T, Ives HE. Strain-responsive regions in the platelet-derived growth factor-A gene promoter. Hypertension. 1998;31(pt 2):170-175.
29. Udenfriend S, Ooshima A, Cardinale G, Fuller GC, Spector S. Increased formation of collagen in the blood vessels of hypertensive rats. Ann N Y Acad Sci. 1976;275:101-103.
30. Bashey RI, Cox R, McCann J, Jimenez SA. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med. 1989;113:604-611.